| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Mastitis Research Laboratory, Hill Farm Research Station, Louisiana Agricultural Experiment Station, Louisiana State University Agricultural Center, Homer 71040
2 USDA, ARS, LPSI, IDRL Building 173 BARC-East, Beltsville, MD 20705
Dairy heifers were treated 0 to 90 d, 90 to 180 d, or 180 to 270 d prepartum with one of five different antibiotic products to determine the best time and with which product they should be treated prior to calving. Two hundred thirty-three heifers were included in the study. At the initial sampling, 56.5% of quarters were infected with some type of organism and 15.4% of quarters were infected with Staphylococcus aureus. Treatments included a cephapirin dry cow product, a penicillin-novobiocin dry cow product, a penicillin-streptomycin dry cow product, an experimental dry cow product containing tilmicosin, and a cephalonium dry cow product not available in the United States. Cure rates for the five antibiotic products indicated that all were equally effective against Staph. aureus and all were significantly more effective than the spontaneous cure rate observed in untreated control quarters. No differences in efficacy were observed due to the different treatment times prepartum. However, fewer new Staph. aureus infections occurred after treatment in the group treated at 180 to 270 d prepartum, indicating that treatment in the third trimester will reduce the chances of new intramammary infections occurring after treatment and persisting to calving.
Key Words: heifers • mastitis • therapy • Staphylococcus aureus
Submitted on June 27, 2000
Accepted on December 6, 2000
This article has been cited by other articles:
|
|
 |
|
  O. C. Sampimon, S. De Vliegher, H. W. Barkema, J. Sol, and T. J. G. M. Lam Effect of prepartum dry cow antibiotic treatment in dairy heifers on udder health and milk production J Dairy Sci, September 1, 2009; 92(9): 4395 - 4403. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. W. Barkema, Y. H. Schukken, and R. N. Zadoks Invited Review: The role of cow, pathogen, and treatment regimen in the therapeutic success of bovine Staphylococcus aureus mastitis. J Dairy Sci, June 1, 2006; 89(6): 1877 - 1895. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. A. Borm, L. K. Fox, K. E. Leslie, J. S. Hogan, S. M. Andrew, K. M. Moyes, S. P. Oliver, Y. H. Schukken, D. D. Hancock, C. T. Gaskins, et al. Effects of prepartum intramammary antibiotic therapy on udder health, milk production, and reproductive performance in dairy heifers. J Dairy Sci, June 1, 2006; 89(6): 2090 - 2098. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Burgos, B. A. Ellington, and M. F. Varela Presence of Multidrug-Resistant Enteric Bacteria in Dairy Farm Topsoil J Dairy Sci, April 1, 2005; 88(4): 1391 - 1398. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. De Vliegher, H. Laevens, H. W. Barkema, I. R. Dohoo, H. Stryhn, G. Opsomer, and A. de Kruif Management Practices and Heifer Characteristics Associated with Early Lactation Somatic Cell Count of Belgian Dairy Heifers J Dairy Sci, April 1, 2004; 87(4): 937 - 947. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
